Literature DB >> 17989856

[Presence of anti hepatitis E virus antibodies in swine: is it an animal reservoir for hepatitis E?].

Humberto Ibarra V1, Stella Riedemann G, German Reinhardt V, Mario Calvo A.   

Abstract

BACKGROUND: Swine hepatitis E virus (HEV) has a cross-reaction with human anti-HEV antibodies. Therefore, pigs could be an animal reservoir, rendering hepatitis E as a zoonosis. The spread of this infection among infected pigs across countries would be possible through trading. Previously, using an anti-human conjugate, we detected anti-HEV antobodies in adult pigs in Chile. AIM: To detect anti-HEV (ELISA) in a cohort of swine at different ages.
MATERIAL AND METHODS: Two hundred pigs aged 42 to 360 days, divided in 20 groups of 10 animals were tested. Anti-HEV was detected by ELISA using anti-pig IgG horseradish peroxidase instead of anti-human conjugates.
RESULTS: Anti-HEV were detected in one animal aged 90 days, two animals aged 120 days, one animal aged 260 days and 2 animals aged 360 days, five pregnant sows and two old hogs. This represents a total of 14 animals or 7% of the sample.
CONCLUSIONS: There is a significant prevalence of anti-HEV in pigs from 90 days of birth, suggesting that these swine are a probable reservoir.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17989856     DOI: 10.4067/s0034-98872007000800006

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  2 in total

Review 1.  Light and Darkness: Prevalence of Hepatitis E Virus Infection among the General Population.

Authors:  José-Manuel Echevarría
Journal:  Scientifica (Cairo)       Date:  2014-02-10

2.  Hepatitis E Virus Genotype 3 in Colombia: Survey in Patients with Clinical Diagnosis of Viral Hepatitis.

Authors:  Julio Rendon; Maria Cristina Hoyos; Diana di Filippo; Fabian Cortes-Mancera; Carolina Mantilla; Maria Mercedes Velasquez; Maria Elsy Sepulveda; Juan Carlos Restrepo; Sergio Jaramillo; Maria Patricia Arbelaez; Gonzalo Correa; Maria-Cristina Navas
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.